ENX-101 is an orally active ( GABA A ) receptor partial positive allosteric modulator (PAM). ENX-101 is selective to α2β2γ2L ( EC 50 = 0.76 nM), α2β3γ2L ( EC 50 = 0.61 nM), α3 ( EC 50 = 1.97 nM), α5 ( EC 50 = 0.85 nM) subunits of GABA receptor . ENX-101 possesses antiseizure activity in several animal models.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GABA Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.